Engineered CRISPR-Cas9 for Streptomyces sp. genome editing to improve specialized metabolite production
Abstract The CRISPR-Cas9 system has frequently been used for genome editing in Streptomyces; however, cytotoxicity, caused by off-target cleavage, limits its application. In this study, we implement innovative modification to Cas9, strategically addressing challenges encountered during gene manipula...
Saved in:
Main Authors: | Duck Gyun Kim, Boncheol Gu, Yujin Cha, Jeonghan Ha, Yongjae Lee, Gahyeon Kim, Byung-Kwan Cho, Min-Kyu Oh |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2025-01-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-025-56278-y |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Antibacterial Activities of Secondary Metabolites Derived from Streptomyces sp.
by: Rabia Mrehil Elsalam, et al.
Published: (2022-12-01) -
Optimization of fermentation conditions to increase the production of antifungal metabolites from Streptomyces sp. KN37
by: Xiaoyue Yang, et al.
Published: (2025-01-01) -
The Rise of CRISPR/Cas for Genome Editing in Stem Cells
by: Bing Shui, et al.
Published: (2016-01-01) -
Principles and medical applications of gene editing by CRISPR / Cas
by: Rolando Sánchez Artigas, et al.
Published: (2021-12-01) -
CRISPR/Cas9-editing of PRNP in Alpine goats
by: Aurélie Allais-Bonnet, et al.
Published: (2025-01-01)